Follicular fluid and serum vascular endothelial growth factor, interleukin (IL)-1β and glycodelin concentrations: comparison between long-gonadotropin-releasing hormone (GnRH)-agonist and GnRH-antagonist cycles: a randomized controlled trial

References

• Marcus SF, Ledger WL. Efficacy and safety of long-acting GnRH agonists in in vitro fertilization and embryo transfer. Hum Fertil 2001;4:85–93
   PubMedGoogle Scholar
• Olivennes F, Fanchin R, Bouchard P, et al. The single or dual administration of the gonadotrophin-releasing hormone antagonist cetrorelix in an in-vitro fertilisation-embryo transfer program. Fertil Steril 1998;62:468–76
   Google Scholar
• Kolibianakis ME, Griesinger G, Tarlatzis BS. GnRH-antagonist in ovarian stimulation for IVF. In: Gardner DK, Weissman A, Howles CM, Shoham Z, eds. Textbook of assisted reproductive techniques. 4th ed. London: Informa Healthcare; 2012: 124–31
   Google Scholar
• Al-Inany HG, Youssef MA, Aboulghar M, et al. Gonadotrophin-releasing hormone antagonists for assisted reproductive technology. Cochrane Database Syst Rev 2011;11:CD001750
   Google Scholar
• Murber A, Fancsovits P, Ledó N, et al. Impact of GnRH analogues on oocyte/embryo quality and embryo development in in vitro fertilization/intracytoplasmic sperm injection cycles: a case control study. Reprod Biol Endocrinol 2009;7:103–6
   PubMed Web of Science ®Google Scholar
• Asimakopoulos B, Nikolettos N, Nehls B, et al. Gonadotropin-releasing hormone antagonists do not influence the secretion of steroid hormones but affect the secretion of vascular endothelial growth factor from human granulosa luteinized cell cultures. Fertil Steril 2006;86:636–41
   PubMed Web of Science ®Google Scholar
• Gougeon A. Regulation intragonadique de la folliculogenese humaine: faits and hypotheses. Ann Endocrinol 1994;55:63–73
   PubMedGoogle Scholar
• Kaipia A, Hsueh A. Regulation of ovarian follicle atresia. Ann Rev Physiol 1997;59:349–63
   PubMed Web of Science ®Google Scholar
• Friedman CI, Seifer DB, Kennard EA, et al. Elevated level of follicular fluid vascular endothelial growth factor is a marker of diminished pregnancy potential. Fertil Steril 1998;70:836–69
   PubMed Web of Science ®Google Scholar
• Asimakopoulos B, Koster F, Felberbaum R, et al. Cytokine and hormonal profile in blood serum and follicular fluids during ovarian stimulation with the multidose antagonist or the long agonist protocol. Hum Reprod 2006;21:3091–5
   PubMedGoogle Scholar
• Lee CL, Lam KK, Koistinen H, et al. Glycodelin-A as a paracrine regulator in early pregnancy. J Reprod Immunol 2011;90:29–34
   PubMedGoogle Scholar
• Leach RE, Jessmon P, Coutifaris C, et al. High throughput, cell type-specific analysis of key proteins in human endometrial biopsies of women from fertile and infertile couples. Hum Reprod 2012;27:814–28
   PubMed Web of Science ®Google Scholar
• Hayes EC, Dominguez CE, Voelkel S, et al. Effect of glycodelin on the production of vascular endothelial growth factor in cumulus cells. Fertil Steril 2006;85:1553–6
   PubMedGoogle Scholar
• Bersinger NA, Birkhäuser MH, Yared M, Wunder DM. Serum glycodelin pattern during the menstrual cycle in healthy young women. Acta Obstet Gynecol Scand 2009;88:1215–21
   PubMed Web of Science ®Google Scholar
• Westergaard LG, Wiberg N, Andersen CY, et al. Circulating concentrations of placenta protein 14 during the natural menstrual cycle in women significantly reflect endometrial receptivity to implantation and pregnancy during successive assisted reproduction cycles. Hum Reprod 1998;13:2612–9
   PubMed Web of Science ®Google Scholar
• Salamonsen LA, Hannan NJ, Dimitriadis E. Cytokines and chemokines during human embryo implantation: roles in implantation and early placentation. Semin Reprod Med 2007;25:437–44
   PubMed Web of Science ®Google Scholar
• Bonetti TC, Salomao R, Brunialti M, et al. Cytokine and hormonal profile in serum samples of patients undergoing controlled ovarian stimulation: interleukin-1beta predicts ongoing pregnancy. Hum Reprod 2010;25:2101–6
   PubMedGoogle Scholar
• World Health Organization. WHO laboratory manual for the examination and processing of human semen. 5th ed. Geneva: World Health Organization; 2010
   Google Scholar
• Alpha Scientists in Reproductive Medicine and ESHRE Special Interest Group of Embryology. The Istanbul consensus workshop on embryo assessment: proceedings of an expert meeting. Hum Reprod 2011;26:1270–83
   PubMed Web of Science ®Google Scholar
• Hohmann FP, Macklon NS, Fauser BC. A randomized comparison of two ovarian stimulation protocols with gonadotropin-releasing hormone (GnRH) antagonist cotreatment for in vitro fertilization commencing recombinant follicle-stimulating hormone on cycle day 2 or 5 with the standard long GnRH agonist protocol. J Clin Endocrinol Metab 2003;88:166–73
   PubMed Web of Science ®Google Scholar
• Katz-Jaffe MG, Linck DW, Schoolcraft WB, Gardner DK. A proteomic analysis of mammalian preimplantation embryonic development. Reproduction 2005;130:899–905
   PubMed Web of Science ®Google Scholar
• Munne S, Magli C, Adler A, et al. Treatment-related chromosome abnormalities in human embryos. Hum Reprod 1997;12:780–4
   PubMed Web of Science ®Google Scholar
• Baka S, Malamitsi-Puchner A. Novel follicular fluid factors influencing oocyte developmental potential in IVF: a review. RBM Online 2006;12:500–6
   Google Scholar
• Mendoza C, Ruiz-Requena E, Ortega E, et al. Follicular fluid markers of oocyte developmental potential. Hum Reprod 2002;17:1017–22
   PubMed Web of Science ®Google Scholar
• Abulafia O, Sherer D. Angiogenesis of the ovary. Am J Obstet Gynecol 2000;182:240–6
   PubMed Web of Science ®Google Scholar
• Barroso G, Barrionuevo M, Rao P, et al. Vascular endothelial growth factor, nitric oxide, and leptin follicular fluid levels correlate negatively with embryo quality in IVF patients. Fertil Steril 1999;72:1024–6
   PubMed Web of Science ®Google Scholar
• Zak T, Kaczmarek A, Wırstleın P, et al. Impact of follicular fluid glycodelin on the process of fertilization and implantation after the transfer of embryos in the process of in vitro fertilization (IVF). Arch Perinatal Med 2010;16:234–7
   Google Scholar
• Karagouni EE, Chryssikopoulos A, Mantzavinos T, et al. Interleukin-1beta and interleukin-1alpha may affect the implantation rate of patients undergoing in vitro fertilization-embryo transfer. Fertil Steril 1998;70:553–9
   PubMedGoogle Scholar